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ABSTRACT 
 
Background: Type 2 Diabetes Mellitus (Type 2 DM) is one of the major causes of morbidity and 
mortality worldwide. Morbidity and mortality due to diabetes are associated with the development 
of various microvascular complications (retinopathy, nephropathy, and neuropathy) and macro-
vascular complications (coronary heart disease, stroke, and peripheral vascular disease). This study 
aimed to examine the determinants of biopsychosocial macro and microvascular complications in 
patients with type 2 DM at Dr. Moewardi Surakarta.  
Subjects and Method: This was an analytic observational with a case-control design. The study 
was conducted at Dr. Moewardi, Surakarta, Central Java, from January to March 2018. A sample of 
75 Type 2 DM cases with complication and 75 Type 2 DM cases without complication was selected 
for this study by fixed disease sampling. The dependent variables were macro and microvascular 
complications. The independent variables were body mass index (BMI), blood pressure, quality of 
life, depression, duration of disease, physical activity, diet, medication adherence, health financing, 
and routine blood sample. Clinical data were taken from medical record. The data of other varia-
bles were collected by a set of pre-tested questionnaire. Logistic regression was employed for data 
analysis.  
Results: The risk of macro and microvascular complications in type 2 DM patients increased with 
high BMI (OR= 22.00; 95% CI= 7.50 to 64.52, p<0.001), poor quality of life (OR= 7.06; CI 95%= 
3.51 to 14.16, p<0.001), depression (OR= 3.30; 95% CI= 1.39 to 7.79, p= 0.007), longer duration of 
disease (OR= 9.71; 95% CI= 2.79 to 33.71, p<0.001), lack of physical activity (OR= 8.16; 95% CI= 
1.23 to 53.93, p=0.029), poor diet (OR= 3.58; 95% CI= 1.39 to 9.18, p=0.008), poor medication 
adherence (OR= 4.54; 95% CI= 1.71 to 12.05, p=0.002), and irregular blood sample control (OR= 
5.80; 95% CI= 1.97 to 14.65, p=0.001).  
Conclusion: The risk of macro and microvascular complications in patients with type 2 DM is de-
termined by BMI, quality of life, depression, duration of disease, physical activity, diet, medication 
adherence, and blood sample control.  
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BACKGROUND 
Type 2 diabetes mellitus (DM) is one of the 
major causes of morbidity and mortality 
worldwide (Cohen et al., 2017). Diabetes 
became one of the greatest global health 
emergencies in the 21st century. Every year, 
more and more people are living with this 
condition, which can result in life-altering 
complications. In addition to the 415 million 
adults estimated to have diabetes today, 
there are 318 million adults with impaired 
glucose tolerance, which puts them at high 
risk for future illness (IDF, 2015). 
Diabetes is associated with the deve-
lopment of various microvascular compli-
cations (retinopathy, nephropathy and neu-
ropathy) and macrovascular complications 
(coronary heart disease, stroke and peri-
Indonesian Journal of Medicine (2018), 3(1): 1-13 
https://doi.org/10.26911/theijmed.2018.03.01.01 
2   e-ISSN: 2549-0265 
pheral vascular disease). In addition to vas-
cular complications, diabetes is also asso-
ciated with other comorbidities, including 
increased risk of malignancy, osteoporosis, 
depression, sleep disorders and reproduc-
tive disorders (Ma, 2016). 
Based on the International Diabetes 
Federation (IDF) data estimation, the DM 
case in 2015 in the world is 415 millions with 
5 millions deaths cases and is estimated to 
reach 642 millions by 2040. The incidence 
of DM is 1 in 11 adults by 2015 and esti-
mated in 2040 to 1 in 10 adults. Indonesia in 
2015 ranks 7th highest in the world that is 
10 million people and estimated the number 
will increase to 16.2 million people in 2040 
and will be ranked the 6th highest in the 
world (IDF, 2015). 
Diabetes ranks second from the main 
priority of non-infectious disease control in 
Central Java at 18.33% (Central Java Pro-
vincial Health Office, 2015). Based on Sura-
karta District health profile, cases of dia-
betes are into the top 10 patterns of disease. 
In 2014, data in Community Health Center 
show that the cases of DM type 2 were about 
17,696 and 11,349 data from the hospital. If 
the prevalence is calculated then a number 
of 6,105 per 100,000 population was ob-
tained. The cases found in 2013 were 4,500 
per 100,000 population (Surakarta City 
Health Office, 2014). Based on the preli-
minary study results in Dr. Moewardi hos-
pital, Surakarta shhow that the visit of DM 
type 2 patients in polyclinic outpatient in 
January 2016 until October 2017 were about 
15,099 people, while those undergoing hos-
pitalization were for about 3114 people. The 
visit of patients with type 2 diabetes mellitus 
was the second largest after hypertension 
disease in polyclinic disease in Dr. Moewar-
di hospital Surakarta.  
The high prevalence of macrovascular 
and microvascular complications in type 2 
diabetes mellitus is an urgent problem that 
must be solved by using an approach model 
capable of assessing various related factors. 
This study employed a biopsychosocial mo-
del approach to assess the determinants 
based on causation and risk factors for ma-
crovascular and microvascular complica-
tions biologically, psychologically and so-
cially. The biopsychosocial model of health 
is a model used to describe biological, psy-
chological and social factors, since the deter-
mination of disease determinants based on 
biological causes alone is not sufficient to 
explain the occurrence of disease processes 
in the body (Murti, 2016). Based on the des-
cription, the researchers are interested to 
examine the determinants of biopsychoso-
cial macrovascular and microvascular com-
plications in patients with type 2 diabetes in 
Dr. Moewardi Hospital, Surakarta. 
 
SUBJECTS AND METHOD 
1. Study Design 
This was an analytic observational study 
with a case control design. The study was 
conducted at Dr. Moewardi hospital, Sura-
karta, Central Java, from January to March 
2018. 
2. Population and Sample 
The source population in this study was 
patient of type 2 DM who underwent treat-
ment at Dr. Moewardi hospital, Surakarta. 
The case population was patient of type 2 
DM patient with macrovascular and micro-
vascular complication who underwent treat-
ment at Dr. Moewardi hospital both in 
outpatient and inpatient for about 150 
samples. Meanwhile, the control population 
was a type 2 DM patient without macrovas-
cular and microvascular complications who 
underwent the treatment of Dr. Moewardi 
for about 75 samples. The sampling used 
fixed disease sampling technique. 
3. Study variable 
The dependent variables were macrovas-
cular and microvascular complications in 
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type 2 DM patients. The independent varia-
bles were Body Mass Index (IMT), blood 
pressure, quality of life, depression, dura-
tion of disease, physical activity, diet, medi-
cation adherence, health financing and 
blood samples (haematology). 
4. Operational definition of variables 
Macrovascular complication of type 2 dia-
betes was defined as complications involving 
larger arterial blood vessels, leading to athe-
rosclerosis which includes coronary heart 
disease, stroke and gangrene in the leg, 
whereas microvascular complications are 
complications of small blood vessels that 
include diabetic retinopathy, diabetic 
nephropathy and diabetic neuropathy.  
Body mass index (BMI) was defined as 
a simple assessment to monitor the nutritio-
nal status of adults, particularly those asso-
ciated with underweight and overweight 
which are calculated as weight in kilograms 
divided by the square of height in meters 
(kg/m2).  
Blood pressure was defined as the 
pressure measured at a pulse expressed in 
millimeters of mercury (mmHg). The data 
were collected by questionnaire. The mea-
surement scale was continuous.  
Quality of life was defined as the 
perception of individuals viewed from the 
cultural context, the value system in which 
they live, the relationship of pleasure, and 
their attention that includes physical, psy-
chological, social, and environmental health 
as measured by using the WHO-Qol BREF 
questionnaire with 26 question items (Dera-
khshanpour et al., 2015). The data were 
collected by questionnaire. The measure-
ment scale was continous, but for the 
purpose of data analysis, it was transformed 
into dichotomous. Coded 1 for bad quality of 
life, coded 0 for good quality of life. 
Depression was defined as subject's 
statement of loss of interest or pleasure, 
guilt or inferiority, disturbed sleep or loss of 
appetite, low energy and decreased concen-
tration as measured by the Beck Depression 
Inventory-II (BDI-II) questionnaire (Zhang 
et al., 2015; Derakhshanpour et al., 2015). 
The measurement scale was continous, but 
for the purpose of data analysis, it was 
transformed into dichotomous. Coded 1 for 
depressed, coded 0 for not depressed. 
The duration of the disease was defi-
ned as the subject's statement about the 
duration/ time of the illness that has been 
suffered by the subject from the time of 
diagnosis by the physician until the study 
was conducted.  
The physical activity was defined as the 
subject's statement of behavior in running 
an activity or physical exercises consisting of 
time spent walking outdoors, time spent in 
sports practice, and contributions to domes-
tic work (Al-Kaabi et al., 2009). The mea-
surement scale was continous, but for the 
purpose of data analysis, it was transformed 
into dichotomous. Coded 1 for not active 
physical activity, coded 0 for active physical 
activity. 
Diet was defined as a statement of the 
subject to the behavior in taking the nutri-
tion therapy by medical personnel whether 
it is in accordance with the type, number 
and schedule of meals recommended in DM 
patient self-care management. The measure-
ment scale was continuous, but for the 
purpose of data analysis, it was transformed 
into dichotomous. Coded 1 for uncontrolled 
diet, coded 0 for controlled diet. 
Treatment obedience was defined as 
the subject's statement on the behavior in 
receiving treatment therapy provided by a 
healthcare provider consisting of drug-
related constraints, barriers about the health 
care system, deliberate obstacles by the 
subject and inadvertent obstacles by the 
subject as measured using a questionnaire 
from ABQ (Adherense Barriers Question-
naire) (Muller et al., 2015). The measure-
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ment scale was continous, but for the 
purpose of data analysis, it was transformed 
into dichotomous. Coded 1 for not obedient, 
coded 0 for obedient. 
Health cost was defined as the amount 
of costs/ money used for treatment based on 
the participation of patients on health insu-
rance related to the health funding sources 
needed to utilize health care and treatment 
efforts. Measurement of health financing is 
based on the participation of DM type 2 
patients in health insurance either managed 
by the government or by the private sector. 
Blood samples are the result of laboratory 
examination of DM type 2 subjects to blood 
samples which become the benchmark of 
health status and were done routinely every 
3 months. Blood samples include: HbA1c, 
Blood Sugar at a Time (GDS), Blood Sugar 2 
Hours after eating, Cholesterol, Trigliseride, 
LDL, HDL, Hb% and Creatinine Serum. The 
measurements were based on laboratory 
results that have been standardized by the 
National Glycohaemoglobin Standarization 
Program (NGSP) and measurements of 
secondary data on hospital medical records. 
5. Study Instruments 
The research instrument used for data col-
lection was a questionnaire that has been 
tested for its validity and reliability. The 
validity test included content and face vali-
dity. The reliability test in was conducted on 
20 patients who underwent treatment Dr. 
Moewardi Hospital, Surakarta, both in case 
population (10) and control (10). The relia-
bility test was performed by measuring the 
variables using the SPSS 22 statistical pro-
gram which can calculate the total-item cor-
relation (≥0.20) and Cronbach alpha 
(≥0.70). 
6. Data Analysis 
The data analysis was conducted using mul-
tiple logistic regression analysis to deter-
mine the magnitude of the influence of 
determinants that affect the occurrence of 
macrovascular and microvascular compli-
cations of patients with type 2 diabetes. 
7. Research Ethics 
The research ethics included informed con-
sent, anonymity, confidentiality and ethical 
clearance. The ethical clearance in this study 
was conducted in Dr. Moewardi Hospital, 
Surakarta. 
 
RESULTS 
1. Sample characteristics 
Table 1 shows that the average of BMI in 
case group (mean= 24.84; SD= 4.28) was 
little higher than in control group (mean= 
24.09; SD= 3.30). The average of systolic 
blood pressure in case group (mean= 
138.37; SD= 26.22) was higher than in 
control group (mean= 134.67; SD= 20.55). 
The control group mostly had good 
quality of life with 63 samples (84%) and in 
the case group mostly with poor quality of 
life of 86 samples (57.3%). In the case group 
(mean= 320.31; SD= 108.71) had longer 
duration of illness than control group 
(mean= 251.47; SD= 81.10).  
The number of patients with depress-
ion was higher in case group (119 patients, 
79.4%) than control group (44 patients, 
58.6%). Active physical activity was higher 
in control group (60 patients, 80%) than in 
case group (61 patients, 40.6%). 
The control group with controlled diet 
consisted of 51 samples (68%) and in the 
case group with uncontrolled diet, there 
were 85 samples (56.7%). The treatment 
obedience variables showed that most of the 
control group adhered to the treatment of 
63 samples (84%) and in the case group 
were largely disobedient in the treatment of 
94 samples (62.7%). Health financing/ cost 
variables indicated that most health insu-
rance had 55 samples (73.3%) in the control 
group and the case group, those who did not 
have health insurance were 76 samples 
(50.7%). The variable of blood sample (hae-
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matology) got result that mostly in control 
group, there were 64 sample (85.3%) con-
trolled blood sample and in case group, 
there were 76 samples (50.7%) of uncon-
trolled blood sample. 
Table 1. The Characteristics of Samples 
Variable 
Status  
Control 
n=75 
Case 
n= 150 
Total 
n=225 
Body Mass Index (Kg/m2) 24.09±3.30 24.84±4.28 24.59±3.99 
Blood Pressure (mmHg) 134.67±20.55 138.37±26.22 137.13±24.49 
Quality of Life    
Good 63 (84%) 64 (42.7%) 127 (56.4%) 
Bad 12 (16%) 86 (57.3%) 98 (43.6%) 
Duration of Illness (Week) 251.47±81.10 320.31±108.71 297.36±105.32 
Depression    
Not Depressed 44 (58,6%) 31 (20.6%) 75 (33.3%) 
Depressed 31 (41,4%) 119 (79.4%) 150 (66.7%) 
Physical Activity    
Active 60 (80%) 61 (40.6%) 121 (53.7%) 
Not Active 15 (20%) 89 (59.4%) 104 (46.3%) 
Diet    
Controlled Diet 51 (68%) 65 (43.3%) 116 (51.6%) 
Uncontrolled Diet 24 (32%) 85 (56.7%) 109 (48.4%) 
Treatment Obedience    
Obedient 63 (84%) 56 (37.3%) 119 (52.9%) 
Not Obedient 12 (16%) 94 (62.7%) 106 (47.1%) 
Health Financing/Cost    
With health insurance  55 (73,3%) 74 (49.3%) 129 (5.3%) 
No health insurance 20 (26,7%) 76 (50.7%) 96 (42.7%) 
Blood Samples    
Controlled blood samples 64 (85,3%) 74 (49.3%) 138 (61.3%) 
Uncontrolled blood samples 11 (14.7%) 76 (50.7%) 87 (38.7%) 
 
2. Bivariate Analysis 
The bivariate analysis was conducted using 
chi-square test and Odds Ratio (OR). Table 
2 shows that there was a positive rela-
tionship between BMI, blood pressure, qua-
lity of life, depression, duration of illness, 
physical activity, diet, medication adheren-
ce, health financing, blood sample, and 
macrovascular and microvascular compli-
cations in patients DM type 2.  
Type 2 diabetes patients with poor 
quality of life had higher risk of macrovas-
cular and microvascular complications than 
patients with type 2 diabetes with good 
quality of life (OR= 3.76; 95% CI = 1.28 to 
11.00; p=0.015). Type 2 diabetes mellitus 
with a duration of illness ≥5 years have a 
risk for macrovascular and microvascular 
complications 3.41 times than patients with 
type 2 diabetes mellitus <5 years (OR= 
3.41; 95% CI= 1.16 to 10.01; p= 0.025). 
Table 3 showed that type 2 DM pa-
tients with depression have a risk for 
macrovascular and microvascular compli-
cations 12.48 times than non-depressed 
type 2 DM patients (OR= 12.48; 95% CI= 
2.99 to 52.05; p=0.001).  
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Table 2. Bivariate Analysis 
Variable 
The Status of DM 
Tipe 2 Total 
OR 95% CI p 
Control Case 
N % n % n % 
BMI (kg/m2)          
Normal 61 73.5 22 26.5 83 100 25.35 12.14-52.93 <0.001 
Not normal 14 9.9 128 90.1 142 100    
Blood Pressure 
(mmHg) 
       
 
 
Normal 53 41.7 74 58.3 127 100 2.47 1.37-4.46 0.002 
Not normal 22 22.4 76 77.6 98 100    
Quality of Life          
Good 63 49.6 64 50.4 127 100 7.05 3.51-14.16 <0.001 
Bad 12 12.2 86 87.8 98 100    
Depression          
Not depressed 44 58.7 31 41.3 75 100 5.44 2.97-9.98 <0.001 
Depressed 31 20.7 119 79.3 150 100    
Duration of Illness 
(Week) 
       
 
 
< 5 years  28 52.8 25 47.2 53 100 2.97 1.57-5.62 0.001 
≥ 5 years 47 27.3 125 72.7 172 100    
Physical Activity          
Active 60 49.6 61 50.4 121 100 5.83 3.03-11.21 <0.001 
Not Active 15 14.4 89 85.6 104 100    
Diet          
Controlled diet 51 44.0 65 56.0 116 100 2.77 1.55-4.97 <0.001 
Uncontrolled diet 24 22.0 85 78.0 109 100    
Treatment Obedience          
Obedient 63 52.9 56 47.1 119 100 8.81 4.37-17.75 <0.001 
Not Obedient 12 11.3 94 88.7 106 100    
Health Financing/ Cost          
With health insurance 55 42.6 74 57.4 129 100 2.82 1.54-5.16 0.001 
No health insurance 20 20.8 76 79.2 96 100    
Blood Samples          
Controlled blood samples 64 46.4 74 53.6 138 100 5.97 2.92-12.21 <0.001 
Uncontrolled blood samples 11 12.6 76 87.4 87 100    
 
Table 3. The results of multivariate analysis 
Independent Variable  OR 
95% CI  
p 
Lower limit Upper limit 
Body mass index 19.88 5.93 66.68 <0.001 
Blood pressure 2.25 0.63 8.03 0.208 
Quality of life 3.76 1.28 11.00 0.015 
The length of illness 3.41 1.16 10.01 0.025 
Depression 12.48 2.99 52.05 0.001 
Physical activity 7.70 2.51 23.62 <0.001 
Diet 4.42 1.52 12.80 0.006 
Medication adherence 4.73 1.62 13.78 0.004 
Health financing 0.57 0.15 2.11 0.401 
Blood samples 4.07 1.40 11.83 0.010 
Observation score 225    
-2 Log likelihood 108.77    
Nagelkerke R2 0.758    
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Type 2 DM patients with inactive phy-
sical activity have a risk for macrovascular 
and microvascular complications by 7.70 
times compared to type 2 DM patients with 
active physical activity (OR= 7.70; 95% CI= 
2.51 to 23.62; p<0.001). 
Type 2 diabetes mellitus patients with 
uncontrolled diet have a risk for macrovas-
cular and microvascular complications by 
4.42 times than type 2 diabetes mellitus pa-
tients who controlled their diet (OR= 4.42; 
95% CI= 1.52 to 12.80; p=0.006) and type 2 
DM patients with non-adherent medication 
have a risk for macrovascular and micro-
vascular complications by 4.73 times than 
type 2 diabetes mellitus patients who have 
medication adherence (OR= 4.73; 95% CI= 
1.62-13.78; p=0.004). 
Type 2 DM patients with uninsured 
health financing have a risk for macrovas-
cular and microvascular complications by 
0.57 time than type 2 DM patients with 
health financing covered by insurance 
(OR= 0.57; 95% CI= 0.15 to 2.11; p=0.401). 
However, the relationship between health 
financing for macrovascular and microvas-
cular complications in type 2 DM patients 
was not statistically significant. 
Patients with type 2 diabetes with un-
controlled blood samples have a risk for 
macrovascular and microvascular compli-
cations by 4.07 times than those of type 2 
DM patients with controlled blood samples 
(OR= 4.07; 95% CI= 1.40 to 11.83; p= 
0.010). 
Based on multivariate analysis, it can 
be concluded that the relationship between 
BMI, quality of life, depression, the length 
of illness, physical activity, diet, medication 
adherence, and blood samples on macro-
vascular and microvascular complications 
in type 2 DM patients was statistically sig-
nificant. 
The results of analysis also found that 
the score of R2 Nagelkerke was 0.758, 
which mean that the eight independent 
variables namely BMI, quality of life, de-
pression, the length of illness, physical acti-
vity, diet, medication adherence, and blood 
samples could explain the variance of 
macrovascular and microvascular compli-
cations in type 2 DM patients by 75.8% and 
the rest 24.2% was explained by other 
factors. 
 
DISCUSSION 
1. The effect of BMI on the macro-
vascular and microvascular com-
plications in patients with type 2 
DM 
The result of this study showed that there 
was an effect of BMI on the macrovascular 
and microvascular complications in pati-
ents with type 2 DM. This study was sup-
ported by Selim (2017), which stated that 
BMI affected the incidence of type 2 DM 
complications. Thomas et al. (2014) stated 
that a significant interaction between age, 
BMI and glycemic levels in relation to the 
risk of cardiovascular complications inci-
dence in patients with type 2 DM. Desh-
pande et al (2008) added that the enhan-
cement of BMI has consistently proven to 
be one of the strongest risk factors for the 
development of DM complications. Bays, 
Chapman & Grandy (2007) also stated that 
the enhancement of BMI was associated 
with increased prevalence of DM, hyper-
tension, and dyslipidemia. 
Type 2 DM patients with abnormal 
BMI have excessive calorie intake. The beta 
cells of the pancreas gland were unable to 
produce enough insulin to balance the ex-
cess calorie intake. As a result, blood glu-
cose levels would be high. Zhao et al (2017) 
stated that higher BMI was associated with 
increased insulin resistance and decreased 
insulin sensitivity in older people with type 
2 DM. 
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2. The effect of life quality on the ma-
crovascular and microvascular 
complications in patients with type 
2 DM  
There was an effect of the quality of life on 
macrovascular and microvascular compli-
cations in patients with type 2 DM. This 
study was supported by a study done by 
Derakhshanpour et al. (2015), which stated 
that quality of life with independent varia-
bles of DM complications showed a signi-
ficant association. 
Sothornwit et al. (2018) stated that 
pain due to ischemia, inability to walk, 
difficulty in treating daily hospital ulcers, 
and unemployment stress can be a major 
cause of lower quality of life among patients 
with diabetic foot complication problems. 
Alcubierre et al. (2014) stated that diabetic 
retinopathy (a microvascular complication) 
was significantly associated with a lower 
quality of life and quality of life was signi-
ficantly affected by the severity of diabetic 
retinopathy. Donald et al. (2013) stated that 
poor glycemic complications and control 
independently reduced the quality of life of 
diabetic patients. 
3. The effect of the duration of illness 
on the macrovascular and micro-
vascular complications in patients 
with type 2 DM 
The result of this study showed that there 
was an effect of the length of illness on the 
macrovascular and microvascular compli-
cations in patients with type 2 DM. This 
study was in accordance with a study done 
by Abu Al-Halaweh et al. (2017) which 
stated that there was a significant rela-
tionship between macrovascular and micro-
vascular complications with the duration of 
diabetes. Natalie et al. (2017) stated that 
age at diagnosis and duration of diabetes 
were all independently associated with an 
increased risk of macrovascular compli-
cations and vice versa, and the duration of 
diabetes was independently associated with 
microvascular complications. 
The result of this study was also sup-
ported by a study done by Hisni et al. 
(2018), which stated that most patients had 
type 2 DM  for >5 years (66.7%) for macro-
vascular complications. Factor which signi-
ficantly associated with complications of 
peripheral neuropathy, retinopathy, and 
diabetic foot was a longer duration of 
diabetes (p<0.001). Khawaja et al (2018) 
stated that duration of diabetes was the 
strongest predictor of neuropathy of dia-
betic peripheral complications, compared 
to patients with type 2 DM who were less 
than 5 years. Patients who had a duration 
of diabetes for 5-11 years (OR= 5.25) and 
≥12 years (OR= 16.98) tend to have peri-
pheral neuropathy complications (p< 
0.001). The result of this study was in line 
with the idea that increased duration of 
type 2 DM was associated with disease pro-
gression (Sazlina et al., 2014). 
4. The effect of depression on the ma-
crovascular and microvascular 
complications in patients with 
Type 2 DM 
The result of this study showed that there 
was an effect of depression on the macro-
vascular and microvascular complications 
in patients with type 2 DM. This study was 
in line with a study done by Rathmann et 
al. (2018) which stated that depression can 
worsen the glycemic control and associated 
to faster complications development. Pan et 
al. (2017) in his study stated that the inci-
dence of depression in patients with micro-
vascular complications (diabetic nephron-
pathy, diabetic retinopathy, diabetic peri-
pheral neuropathy) was significantly higher 
than patients without microvascular com-
plications. 
People with type 2 DM would have 
higher levels of depression and were di-
rectly related to hyperglycemia. Conditions 
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of hyperglycemia in a long time would be 
damaged in various organs. The damage to 
these organs was a complication of type 2 
DM, therefore, it would make people with 
type 2 DM to be more depressed. Zhang et 
al. (2015) explained that type 2 DM pati-
ents with depressive symptoms had more 
complications than non-depressed patients. 
5. The effect of physical activity on 
the macrovascular and microvas-
cular complications in patients 
with type 2 DM. 
The result of this study showed that there 
was an effect of physical activity on the 
macrovascular and microvascular compli-
cations in patients with type 2 DM. This 
study was in line with a study done by Balk 
et al. (2015) which stated that diet and 
physical activity reduced risk the factors for 
cardiovascular disease. Blomster et al. 
(2013) stated that diabetic patients who 
reported moderate to severe activity were 
15% less likely to have microvascular inci-
dence. 
Riddell and Burr (2011) stated that re-
gular exercise lowered long-term risk for 
cardiovascular disease complications in 
people with type 2 DM. Regular physical 
activity can regulate blood sugar levels bet-
ter and prevent the complications of DM. 
Fox et al (2015) stated that physical activity 
interventions lead to the improvement in 
risk factors for cardiovascular disease. Lin 
et al. (2010) have found that most people 
with risk factors such as smoking (20%), 
obesity (57%), overweight (85%), and less 
physical activity (36%) can developed 
microvascular complications. 
6. The effect of diet on the macro-
vascular and microvascular com-
plications in patients with type 2 
DM 
The result of this study showed that there 
was an effect of diet on the macrovascular 
and microvascular complications in pati-
ents with type 2 DM. This study was in line 
with a study done by Meng et al. (2017) 
which stated that the risk factors for 
cardiovascular complications in type 2 DM, 
low-carb dietary interventions significantly 
reduced triglyceride concentrations and 
increased HDL cholesterol concentrations. 
Dietary habits were an important element 
of cardiovascular disease risk and indi-
vidual metabolism (Elmazar et al., 2014). 
Metabolic control can be considered 
as a basis in diabetes management and its 
complications. A study showed that dietary 
intake of olive oil in the Mediterranean 
region had a beneficial effect on the reduc-
tion of retinopathy development in patients 
with type 2 DM (Al-Sinani et al., 2010).  
The implementation of dietary modifi-
cation has a beneficial clinical effect and an 
adequate nutritional intake in diabetic pa-
tients. On the diabetic diet, it showed lower 
total cholesterol, triglyceride, and AST (as-
partate amino transferase) levels (Cho, Shin 
& Chung, 2014). 
7. The effect of medication adherence 
on the macrovascular and micro-
vascular complications in patients 
with type 2 DM 
The result of this study showed that there 
was an effect of medication adherence on 
the macrovascular and microvascular com-
plications in patients with type 2 DM. This 
study was in line with a study done by Li et 
al (2018) which stated that poor adherence 
to medication (AHR= 1.20; 95% CI= 1.06 to 
1.35) when compared togood adherence 
was a predictor of macrovascular compli-
cations in type 2 DM.  
Sloan et al. (2004) stated that adhe-
rence and blood glucose and lipid test were 
often associated with reduced frequency of 
hospitalization in DM patients, including 
for vascular and kidney complications. 
Polonsky and Henry (2016) stated that poor 
adherence was associated with inadequate 
glycemic control, increased use of health 
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care resources, higher medical costs, and 
higher mortality rates.  
8. The effect of blood samples on the 
macrovascular and microvascular 
complications in patients with 
Type 2 DM  
The result of this study showed that there 
was an effect of blood samples on the 
macrovascular and microvascular com-
plications in patients with type 2 DM. This 
study was supported by a study done by 
Khanam et al (2017) which stated that the 
average with standard deviation (SD), age, 
systole blood pressure, diastolic blood 
pressure, HbA1c, fasting blood sugar, blood 
sugar 2 hours after meals, and serum 
creatinine were found to have significantly 
higher risk for complications compared to 
the subjects who did not have compli-
cations. The result of this study also showed 
that duration levels of diabetes and Hb% 
were significantly more in those who did 
not have complications compared to sub-
jects with complications. 
The result of this study was also in 
line with a study by Abu Al-Halaweh et al 
(2017), which stated that the average of 
HbA1c for patients with microvascular di-
sease was 9.99% (SD= 2.12) compared to 
8.89% (SD= 1.93, p<0.001) for those with-
out microvascular complications. The ave-
rage of HbA1c for patients with macro-
vascular disease was 9.44% (SD= 2.02) 
compared to 9.18% (SD= 2.04) for those 
without macrovascular disease (p= 0.11). 
Hisni et al. (2018) on the result of his 
study showed that after getting self-mana-
gement support, the experimental group 
participants showed significant differences 
in fasting blood sugar, total cholesterol, 
HDL cholesterol, systolic blood pressure, 
and diastolic blood pressure before and 
after receiving the program, on the prevent-
ion of cardiovascular complications beha-
vior in older people with uncontrolled type 
2 DM. The result of this study was also 
supported by a study done by Selim (2017) 
which stated that blood samples of 
cholesterol, LDL, HDL, trigliserid affected 
the incidence of type 2 DM complications 
retinopathy (OR= 1.17; 95% CI= 0.73 to 
1.87, diabetic foot ulcers (OR= 2.32, 95% 
CI= 1.14 to 4.01), and coronary arteries 
(OR= 1.03; 95% CI= 0.64 to 1.66). 
Based on the results of this study, it 
can be concluded that the risk of macro-
vascular and microvascular complications 
in patients with type 2 DM was the deter-
minants of BMI, quality of life, depression, 
the length of illness, physical activity, diet, 
medication adherence, and blood sample 
control. 
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